After a disastrous end to 2018, pharma stocks have started the New Year on a considerably strong note. Here are several biotech stocks which would be a smart choice to invest in.

Columbia China has begun construction on a $150 million 500-bed multi-specialty hospital in Jiaxing, Zhejiang Province. The new hospital, which is Columbia's second in China, will open in 2019.

Aduro Biotech Fell as much as 22% as soon as news was announced; Ended the day down by only 4%

Phase 2b study fails to echo phase 2a results; survival improvement is statistically insignificant. Could this also be bad news for Advaxis?

The biotech sector is usually immune to macro events but today the crisis in Greece gave investors an excuse to take profits. Many biotech stocks and ETFs were down over 3% faring worse than the NASDAQ down 2.4%.

Monday’s Pre-Market Insights: ROSE, ZU, ADRO, ETSY.

This will be a big week for the market with 25% of all S&P companies reporting earnings. The leading sectors are technology, telecom and utilities with healthcare lagging but up 0.4%. Major biotech ETFs are slightly green.

Biotech indices and ETFs are trying to hit new highs but momentum is easing and trading is choppy. Nonetheless we are moving up from the brief correction near channel lows at the end of Q1. Sentiment remains strong.

Party City Holdco Inc.began trading on the New York Stock Exchange today, Apr 16. The initial public offering of 21.9 million shares are priced at $17.00 per share, at par with lower end of the expected range of $17 to $19 per share.